Is Genpact Ltd. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 14, an EV to EBITDA of 10.29, and a Price to Book Value of 3.09. In comparison to peers, ICON plc has a P/E of 14.64, while Booz Allen Hamilton Holding Corp. has a P/E of 15.81, suggesting that Genpact is positioned competitively within its industry.
Despite its fair valuation, Genpact has underperformed against the S&P 500 in various timeframes, particularly over the last three years, where it returned -12.78% compared to the S&P 500's 81.19%. This underperformance may indicate that while the stock is fairly valued, it may not be the best investment opportunity relative to broader market performance.